158 related articles for article (PubMed ID: 31668797)
21. Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study.
Jha V; Biagi M; Spinelli V; Di Stefano M; Macchia M; Minutolo F; Granchi C; Poli G; Tuccinardi T
Molecules; 2020 Dec; 26(1):. PubMed ID: 33375358
[TBL] [Abstract][Full Text] [Related]
22. 4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors.
Granchi C; Rizzolio F; Bordoni V; Caligiuri I; Manera C; Macchia M; Minutolo F; Martinelli A; Giordano A; Tuccinardi T
J Enzyme Inhib Med Chem; 2016; 31(1):137-46. PubMed ID: 25669350
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase.
Lauria S; Perrotta C; Casati S; Di Renzo I; Ottria R; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
Bioorg Med Chem; 2018 May; 26(9):2561-2572. PubMed ID: 29678535
[TBL] [Abstract][Full Text] [Related]
24. Monoacylglycerol lipase (MAGL) inhibitors based on a diphenylsulfide-benzoylpiperidine scaffold.
Bononi G; Tonarini G; Poli G; Barravecchia I; Caligiuri I; Macchia M; Rizzolio F; Demontis GC; Minutolo F; Granchi C; Tuccinardi T
Eur J Med Chem; 2021 Nov; 223():113679. PubMed ID: 34218085
[TBL] [Abstract][Full Text] [Related]
25. 1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling.
Käsnänen H; Minkkilä A; Taupila S; Patel JZ; Parkkari T; Lahtela-Kakkonen M; Saario SM; Nevalainen T; Poso A
Eur J Pharm Sci; 2013 Jun; 49(3):423-33. PubMed ID: 23557840
[TBL] [Abstract][Full Text] [Related]
26. The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL).
Zhu B; Connolly PJ; Zhang SP; Chevalier KM; Milligan CM; Flores CM; Macielag MJ
Bioorg Med Chem Lett; 2020 Jun; 30(12):127198. PubMed ID: 32334914
[TBL] [Abstract][Full Text] [Related]
27. Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2
Ikeda S; Sugiyama H; Tokuhara H; Murakami M; Nakamura M; Oguro Y; Aida J; Morishita N; Sogabe S; Dougan DR; Gay SC; Qin L; Arimura N; Takahashi Y; Sasaki M; Kamada Y; Aoyama K; Kimoto K; Kamata M
J Med Chem; 2021 Aug; 64(15):11014-11044. PubMed ID: 34328319
[TBL] [Abstract][Full Text] [Related]
28. Set-Up and Validation of a High Throughput Screening Method for Human Monoacylglycerol Lipase (MAGL) Based on a New Red Fluorescent Probe.
Miceli M; Casati S; Ottria R; Di Leo S; Eberini I; Palazzolo L; Parravicini C; Ciuffreda P
Molecules; 2019 Jun; 24(12):. PubMed ID: 31208066
[TBL] [Abstract][Full Text] [Related]
29. The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors.
Zhu B; Connolly PJ; Zhang YM; McDonnell ME; Bian H; Lin SC; Liu L; Zhang SP; Chevalier KM; Brandt MR; Milligan CM; Flores CM; Macielag MJ
Bioorg Med Chem Lett; 2020 Jul; 30(14):127243. PubMed ID: 32527545
[TBL] [Abstract][Full Text] [Related]
30. beta-Lactams derived from a carbapenem chiron are selective inhibitors of human fatty acid amide hydrolase versus human monoacylglycerol lipase.
Feledziak M; Michaux C; Urbach A; Labar G; Muccioli GG; Lambert DM; Marchand-Brynaert J
J Med Chem; 2009 Nov; 52(22):7054-68. PubMed ID: 19877691
[TBL] [Abstract][Full Text] [Related]
31. Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors.
Granchi C; Caligiuri I; Bertelli E; Poli G; Rizzolio F; Macchia M; Martinelli A; Minutolo F; Tuccinardi T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1240-1252. PubMed ID: 28936880
[TBL] [Abstract][Full Text] [Related]
32. Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors.
Bononi G; Granchi C; Lapillo M; Giannotti M; Nieri D; Fortunato S; Boustani ME; Caligiuri I; Poli G; Carlson KE; Kim SH; Macchia M; Martinelli A; Rizzolio F; Chicca A; Katzenellenbogen JA; Minutolo F; Tuccinardi T
Eur J Med Chem; 2018 Sep; 157():817-836. PubMed ID: 30144699
[TBL] [Abstract][Full Text] [Related]
33. Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold.
Morera L; Labar G; Ortar G; Lambert DM
Bioorg Med Chem; 2012 Nov; 20(21):6260-75. PubMed ID: 23036333
[TBL] [Abstract][Full Text] [Related]
34. New diterpenes from Salvia pseudorosmarinus and their activity as inhibitors of monoacylglycerol lipase (MAGL).
De Leo M; Huallpa CG; Alvarado B; Granchi C; Poli G; De Tommasi N; Braca A
Fitoterapia; 2018 Oct; 130():251-258. PubMed ID: 30240845
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.
Granchi C; Bononi G; Ferrisi R; Gori E; Mantini G; Glasmacher S; Poli G; Palazzolo S; Caligiuri I; Rizzolio F; Canzonieri V; Perin T; Gertsch J; Sodi A; Giovannetti E; Macchia M; Minutolo F; Tuccinardi T; Chicca A
Eur J Med Chem; 2021 Jan; 209():112857. PubMed ID: 33045662
[TBL] [Abstract][Full Text] [Related]
36. Radiosynthesis and ex vivo evaluation of [(11)C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors.
Hicks JW; Parkes J; Tong J; Houle S; Vasdev N; Wilson AA
Nucl Med Biol; 2014 Sep; 41(8):688-94. PubMed ID: 24969632
[TBL] [Abstract][Full Text] [Related]
37. Rational Development of MAGL Inhibitors.
Granchi C; Rizzolio F; Caligiuri I; Macchia M; Martinelli A; Minutolo F; Tuccinardi T
Methods Mol Biol; 2018; 1824():335-346. PubMed ID: 30039417
[TBL] [Abstract][Full Text] [Related]
38. Analgesic and Anticancer Activity of Benzoxazole Clubbed 2-Pyrrolidinones as Novel Inhibitors of Monoacylglycerol Lipase.
Afzal O; Altamimi ASA; Shahroz MM; Sharma HK; Riadi Y; Hassan MQ
Molecules; 2021 Apr; 26(8):. PubMed ID: 33924091
[TBL] [Abstract][Full Text] [Related]
39. Development of Thiazole-5-carboxylate Derivatives as Selective Inhibitors of Monoacylglycerol Lipase as Target in Cancer.
Ali MR; Kumar S; Shalmali N; Afzal O; Azim S; Chanana D; Alam O; Paudel YN; Sharma M; Bawa S
Mini Rev Med Chem; 2019; 19(5):410-423. PubMed ID: 29962341
[TBL] [Abstract][Full Text] [Related]
40. In Vivo Characterization of the Ultrapotent Monoacylglycerol Lipase Inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl}(1H-1,2,4-triazol-1-yl)methanone (JJKK-048).
Aaltonen N; Kedzierska E; Orzelska-Górka J; Lehtonen M; Navia-Paldanius D; Jakupovic H; Savinainen JR; Nevalainen T; Laitinen JT; Parkkari T; Gynther M
J Pharmacol Exp Ther; 2016 Oct; 359(1):62-72. PubMed ID: 27451409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
